Home › NDC Lookup › Ingredients › Capsaicin › 67510-0303-02
Capsaicin Pain Relief .702 mg Patch, 2 patches — NDC 67510-0303-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Capsaicin Pain Relief .702 mg Patch, 2 patches — NDC 67510-0303-2 (Billing 67510-0303-02)

by Kareway Product, Inc. · 2 PATCH in 1 POUCH

This is a package of 2 patches of Capsaicin Pain Relief .702 mg Patch from Kareway Product, Inc., marketed since Jan 2012 and currently FDA-listed.

NDC 67510-0303-02
🏷️ FDA NDC (as labeled) 67510-0303-2 billing pads the package segment with a zero
This package
Contains2 patches Pack sizes2 compare ↓
Product page 67510-0303-01 Also comes in: 1 patch 67510-0303-1
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 67510-0303-2 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
67510 labeler · 0303 product · 2 package
Package marketed since
May 18, 2018
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 6751003032 4
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 67510-0303-2
Product NDC 67510-0303
11-digit billing NDC 67510030302
RxCUI 1043399
UNII S07O44R1ZM
Application # part348
SPL Set ID dce9db37-cd07-44d8-8881-f63a2191964f
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH NOT FINAL
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2012-01-23
Route TOPICAL
Dosage form PATCH
Substance CAPSAICIN
Quick answers
  • RxCUI (RxNorm): 1043399
Why two NDCs? The FDA registers this code as 67510-0303-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 67510-0303-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Capsaicin and similar agents class.

Drug family (ATC) Capsaicin and similar agents, Other local anesthetics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • Yes, completely normal — and it actually means the medicine is working. Capsaicin activates the same pain-sensing receptors in your skin that respond to heat and spicy food. That b...
  • Why does capsaicin burn when I put it on? Is that normal?
  • For most OTC creams and ointments, you can apply up to 3 to 4 times a day. For OTC patches, apply to clean, dry skin and remove after no more than 8 hours — again, up to 3 to 4 tim...
  • How often should I apply capsaicin cream or use the patch?
📖 Read our full Capsaicin guide →

Supplement & herbal interactions

Some supplements/herbs that may interact with Capsaicin (prescription drug) — tap one for details:

Dimethylsulfoxide (dmso)Moderate Turpentine OilModerate AlchemillaMinor
🌿 Every supplement checked against Capsaicin (prescription drug) (3 interactions) — ranked by severity →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 1 patch
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
67510-0303-01 67510-0303-1 Main listing 1 POUCH in 1 CARTON / 1 PATCH in 1 POUCH 2012-01-23 — Active
67510-0303-02 You're viewing this 2 PATCH in 1 POUCH 2018-05-18 — Active

Pack size FAQ

What quantity is in this package?
This package contains 2 patches — 2 patch in 1 pouch.
How does this package differ from NDC 67510-0303-01?
Both are Capsaicin Pain Relief .702 mg Patch — the drug itself is identical. This page's package is the 2 patches one, while NDC 67510-0303-01 is the 1 patch package.
What NDC number is used to bill for this package of Capsaicin Pain Relief .702 mg Patch?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Neighbor Capsaicin Heat Patch for Back .025 g/100g 46122-0753-55 Amerisource 3 patches $1.117 — Availability likely —
Capsaicin Hot Patches .025 g/100g 70000-0556-01 Cardinal 2 patches $1.117 — Availability likely —
Capsimide .025 g/100g 70512-0016-10 Sola 10 pouches $1.117 — Availability likely —
Walgreens Capsaicin Hot Patch .25 mg/g 00363-6691-03 Walgreen 3 patches — — FDA listed —
Capsaicin Heat Patches Back And Large Areas .025 g/100g 00363-9902-03 Walgreen 3 patches — — FDA listed —
WellPatch Warming Pain Relief 25 mg 10742-8127-01 The 1 patch — — FDA listed —
Capsaicin Heat Patches Pain Relief .025 g/100g 11822-4210-03 Rite 3 patches — — FDA listed —
Capsaicin Heat Patches Back And Large Areas .025 g/100g 41250-0842-03 Meijer 3 patches — — FDA listed —
Salonpas-Hot Capsicum .025 g/100g 46581-0700-01 Hisamitsu 1 patch — — Discontinued —
Equate Capsaicin Pain Relieving .25 mg/g 49035-0890-01 Wal-Mart 1 patch — — FDA listed —
Satogesic Hot .25 mg 49873-0608-01 Sato 5 patches — — FDA listed —
Capsaicin .025 g/100g 50488-2025-01 Alexso, 10 patches — — FDA listed —
Capsaicin Heat .025 g/100g 52000-0040-41 Universal 2 patches — — FDA listed —
Solstice Capsaicin Patch Hot .025 g/100g 55614-0410-01 MADISON 1 patch — — FDA listed —
CVS Medicated Heat 1 ct .025 g/g 59779-0770-01 CVS 1 g — — FDA listed —
Best Choice Targeted Warming Capsaicin Heat Patch .025 g/100g 63941-0691-03 Valu 3 patches — — FDA listed —
Coralite Medicated Heat 249 mg 65923-0123-01 United 1 patch — — FDA listed —
Coralite Capsaicin Heat Patch 2ct 249 mg/g 65923-0809-02 United 1 patch — — FDA listed —
Capsaicin Pain Relief .702 mgthis 67510-0303-02 Kareway 2 patches — — FDA listed —
Capsaicin .025 g/100g 69420-7025-01 SA3, 10 patches — — FDA listed —
Capsaicin .025 g/100g 71436-3025-01 ARI 10 patches — — FDA listed —
Pain Relieving Gel-Patch .00025 g/g 73557-0180-05 Shanghai 5 patches — — FDA listed —
BonicaEaseX Hot Capsicum Pain Relieving .25 mg 75568-0042-00 Planet 24 patches — — FDA listed —
Meijer Capsaicin Heat Patch .025 g/100g 79481-0064-03 Meijer 3 patches — — FDA listed —
Capsaicin .025 g/100g 79643-0002-01 PHARMACURE 10 patches — — FDA listed —
Capsaicin 0.025% 2.5 mg/10g 80425-0541-01 Advanced 30 patches — — FDA listed —
CAPSAICIN HEAT Patch .025 g/1001 83559-0013-01 Henan 48 patches — — FDA listed —
Rapid Relief .00025 g/g 83569-0018-06 RAPID 6 patches — — FDA listed —
Honest Med Capsaicin Patch .025 g/100g 84097-0003-24 Proper 24 patches — — FDA listed —
Capsaicin 0.025% 2.5 mg/10g 85096-0401-30 Marcella 30 patches — — FDA listed —
0.025% Capsaicin Pain relief Patch .025 g/100g 85323-0001-00 Xuzhou 5 patches — — FDA listed —
0.025% Capsaicin Pain relief Patch .025 g/100g 85323-0005-01 Xuzhou 48 patches — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2012
On the market since
Jan 2012
📍
2026
Currently FDA-listed
14 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Capsaicin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerKareway Product, Inc.
FDA applicationpart348 (OTC MONOGRAPH NOT FINAL)
Labeler code67510
First marketedJan 2012
Product typeHuman Otc Drug
Portfolio6 products on file

More NDCs from Kareway Product, Inc. labeler code 67510

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 21 words ▾

Uses For temporary relief of minor aches and pains of muscles and joints associated with: simple backache arthritis strains bruises sprains

⏱️ Dosage and Administration 54 words ▾

Directions Adults and children 12 years of age and over: Clean and dry affected area Remove patch from film Apply to affected area not more than 3 to 4 times daily for 7 days Remove patch from the skin after at most 8 hour's application Children under 12 years of age: Consult a doctor

⚠️ Warnings 128 words ▾

Warnings For external use only. Discontinue use at least 1 hour before a bath or shower and do not use immediately after a bath or shower. Do not use on wounds or damaged skin with a heating pad with, or at the same times as other external analgesic products if you are allergic to any ingredients of this product When using this product use only as directed avoid contact with the eyes, mucous membranes or rashes Stop use and ask a doctor if rash, itching or excessive skin irritation develops conditions worsen symptoms persist for more than 7 days symptoms clear up and occur again within a few days Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 13 words ▾

Other information Avoid storing product in direct sunlight Protect product from excessive moisture

🧪 Active Ingredient 7 words ▾

Active ingredient Capsicum extract 0.025% as Capsaicin

🧪 Inactive Ingredients 10 words ▾

Inactive ingredients hydrogenated poly, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, petroleum, styrene/isoprene copolymer

🎯 Purpose 3 words ▾

Purpose Topical analgesic

📄 Do Not Use 33 words ▾

Do not use on wounds or damaged skin with a heating pad with, or at the same times as other external analgesic products if you are allergic to any ingredients of this product

📄 When Using This Product 17 words ▾

When using this product use only as directed avoid contact with the eyes, mucous membranes or rashes

📄 Stop Use and Ask a Doctor If 33 words ▾

Stop use and ask a doctor if rash, itching or excessive skin irritation develops conditions worsen symptoms persist for more than 7 days symptoms clear up and occur again within a few days

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 6 words ▾

Package label Capsaicin Hot Patch label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Capsaicin Pain Relief (this brand).

Top reported reactions

Fatigue141
Weight Increased99
Pain91
Insomnia89
Poor Quality Sleep75
Hypertension71
Cataract68

Age at onset

Child2
Adolescent4
Adult140
Elderly79

Reporter sex

1,399 reports
Male · 43%
Female · 56%
Unknown · 0%

Serious outcomes

Hospitalization427
Disabling76
Death73
Life-threatening56
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 136 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Not Final". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Kareway Product, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 patch (67510-0303-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Kareway Product, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 67510-0289-01 · Kareway 67510-0305-02 · Kareway →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.